Rajesh Chopra
Vorstandsvorsitzender bei Aethon Therapeutics, Inc.
Aktive Positionen von Rajesh Chopra
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 11.02.2019 | - |
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Private Equity Investor | 01.04.2020 | - |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - | - |
Aethon Therapeutics, Inc.
Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services The company, co-founded by venture capital firm Apple Tree Partners and New York University cancer researchers Shohei Koide, Ph.D., and Benjamin G. Neel, Ph.D., unites immunotherapy and targeted therapy to expand the power and promise of both approaches for people living with cancer. Aethon Therapeutics, Inc. is based in New York, NY. Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that creates neoantigens by design to transform cancer treatments into cures. The company's novel anti-drug-peptide conjugate/mhc antibodies are designed to be used in combination with targeted covalent inhibitors of ras, egfr, and other oncogenic driver mutations to mount immune attacks and selectively kill residual cancer cells, including drug-resistant "persister" cells. The company was founded by Benjamin G. Neel, Shohei Koide. The CEO is Rajesh Chopra. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - |
Karriereverlauf von Rajesh Chopra
Ehemalige bekannte Positionen von Rajesh Chopra
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CELGENE | Corporate Officer/Principal | 01.04.2009 | 01.01.2016 |
E-THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 06.02.2012 | 29.10.2015 |
Independent Dir/Board Member | 06.02.2012 | 29.10.2015 | |
ASTRAZENECA PLC | Corporate Officer/Principal | 01.04.2004 | 01.04.2009 |
The Christie NHS Foundation Trust | Corporate Officer/Principal | - | - |
Ausbildung von Rajesh Chopra
University College London | Doctorate Degree |
The UCL Academy | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 7 |
Vereinigte Staaten | 5 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Undergraduate Degree | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
E-THERAPEUTICS PLC | Health Technology |
ASTRAZENECA PLC | Health Technology |
Private Unternehmen | 6 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
The Christie NHS Foundation Trust | Miscellaneous |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Finance |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA. | Health Technology |
Aethon Therapeutics, Inc.
Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services The company, co-founded by venture capital firm Apple Tree Partners and New York University cancer researchers Shohei Koide, Ph.D., and Benjamin G. Neel, Ph.D., unites immunotherapy and targeted therapy to expand the power and promise of both approaches for people living with cancer. Aethon Therapeutics, Inc. is based in New York, NY. Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that creates neoantigens by design to transform cancer treatments into cures. The company's novel anti-drug-peptide conjugate/mhc antibodies are designed to be used in combination with targeted covalent inhibitors of ras, egfr, and other oncogenic driver mutations to mount immune attacks and selectively kill residual cancer cells, including drug-resistant "persister" cells. The company was founded by Benjamin G. Neel, Shohei Koide. The CEO is Rajesh Chopra. | Health Services |
- Börse
- Insiders
- Rajesh Chopra
- Erfahrung